FAP is commonly targeted with radiotracers such as Fibroblast Activation Protein Inhibitors (FAPIs), which specifically bind to FAP, enabling precise imaging and potential therapeutic intervention in tumor-associated stromal cells [157,158,159]. The gene discussed is FAP; the disease is neoplasm.